Peg is a well-respected expert in the pharmaceutical industry, bringing nearly 30 years of experience in medical affairs and clinical research. In 2008, Peg founded Zipher Medical Affairs, LLC., a leading provider of medical affairs strategic consulting and MSL services. Since inception, Peg has served as President. She has successfully led late-stage biotech and pharmaceutical companies through multiple product launches across several therapeutic areas, such as oncology, cardiovascular, and diabetes. Peg's patient-centric view and drive for improved patient care and outcomes have propelled her to shape the organization based on not only scientific integrity but also continual collaboration with emerging medical stakeholders.
Earlier in her career, Peg held appointments as Assistant Professor at Harvard Medical School (‘97–‘02) and the University of Pittsburgh School of Medicine (‘93–‘97), establishing her scientific credibility in the research and medical communities.
Following a career in academia, Peg joined industry and gained valuable experience providing scientific support for physicians as a medical science liaison and a liaison manager for Berlex Laboratories, a US branch of the former German pharmaceutical giant Schering AG. She subsequently joined Bayer Healthcare Pharmaceuticals where she was Medical Director and later appointed Head of Global Oncology Publications and Communications. Peg was responsible for strategic communications planning, execution, and global roll-out for Nexavar® during the renal cell and hepatocellular carcinoma launches.
Peg received a Ph.D. in 1991 from the University of Alabama at Birmingham in the field of immunology and an M.B.A. in 2000 from Simmons School of Management.